CUSIP No. 379606106
|
Schedule 13G
|
Page 2 of 11 Pages
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
Oxford Bioscience Partners V L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
|
5
|
SOLE VOTING POWER
4,103,739
|
|
SHARES
BENEFICIALLY
OWNED BY
|
6
|
SHARED VOTING POWER
4,196,221
|
|
EACH
REPORTING
PERSON
|
7
|
SOLE DISPOSITIVE POWER
4,103,739
|
|
WITH
|
8
|
SHARED DISPOSITIVE POWER
4,196,221
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,196,221
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
CUSIP No. 379606106
|
Schedule 13G
|
Page 3 of 11 Pages
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
mRNA Fund V L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
|
5
|
SOLE VOTING POWER
92,482
|
|
SHARES
BENEFICIALLY
OWNED BY
|
6
|
SHARED VOTING POWER
4,196,221
|
|
EACH
REPORTING
PERSON
|
7
|
SOLE DISPOSITIVE POWER
92,482
|
|
WITH
|
8
|
SHARED DISPOSITIVE POWER
4,196,221
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,196,221
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
CUSIP No. 379606106
|
Schedule 13G
|
Page 4 of 11 Pages
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
OBP Management V L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
|
5
|
SOLE VOTING POWER
0
|
|
SHARES
BENEFICIALLY
OWNED BY
|
6
|
SHARED VOTING POWER
4,196,221
|
|
EACH
REPORTING
PERSON
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
WITH
|
8
|
SHARED DISPOSITIVE POWER
4,196,221
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,196,221
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
CUSIP No. 379606106
|
Schedule 13G
|
Page 5 of 11 Pages
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
Jonathan Fleming
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
||
NUMBER OF
|
5
|
SOLE VOTING POWER
0
|
|
SHARES
BENEFICIALLY
OWNED BY
|
6
|
SHARED VOTING POWER
4,196,221
|
|
EACH
REPORTING
PERSON
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
WITH
|
8
|
SHARED DISPOSITIVE POWER
4,196,221
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,196,221
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
|
CUSIP No. 379606106
|
Schedule 13G
|
Page 6 of 11 Pages
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
Matthew Gibbs
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
||
NUMBER OF
|
5
|
SOLE VOTING POWER
0
|
|
SHARES
BENEFICIALLY
OWNED BY
|
6
|
SHARED VOTING POWER
4,196,221
|
|
EACH
REPORTING
PERSON
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
WITH
|
8
|
SHARED DISPOSITIVE POWER
4,196,221
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,196,221
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
|
CUSIP No. 379606106
|
Schedule 13G
|
Page 7 of 11 Pages
|
|
Glori Energy Inc.
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
Item 2(a).
|
Names of Persons Filing:
|
|
This statement is being filed by Oxford Bioscience Partners V L.P. (“OBP V”); mRNA Fund V L.P. (“mRNA V”); OBP Management V L.P. (“OBP V GP”), which is the sole general partner of OBP V and mRNA V; and Jonathan Fleming (“Fleming”) and Matthew Gibbs (“Gibbs”) (collectively, the “General Partners”). The General Partners are the individual general partners of OBP V GP. OBP V, mRNA V, OBP V GP and the General Partners are sometimes referred to collectively herein as the “Reporting Persons”.
|
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
|
The address of the principal business office of OBP V, mRNA V, OBP V GP and the General Partners is Oxford Bioscience Partners, 535 Boylston Street, Suite 402, Boston, MA 02116.
|
Item 2(c).
|
Citizenship:
|
|
Each of OBP V, mRNA V and OBP V GP is a Delaware limited partnership. Each of the General Partners is a United States citizen.
|
Item 2(d).
|
Title of Class of Securities:
|
|
Common Stock, $.0001 par value (“Common Stock”).
|
Item 2(e).
|
CUSIP Number:
|
|
379606106.
|
Item 3.
|
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
Not applicable.
|
(a)
|
Amount Beneficially Owned: OBP V is the record owner of 4,103,739 shares of Common Stock as of April 14, 2014 (the “OBP V Shares”). mRNA V is the record owner of 92,482 shares of Common Stock as of April 14, 2014 (the “mRNA Shares” and, together with the OBP V Shares, the “Shares”). As the sole general partner of OBP V and mRNA V, OBP V GP may be deemed to own beneficially the Shares. As the individual General Partners of OBP V GP, each of the General Partners also may be deemed to own beneficially the Shares.
|
(b)
|
Percent of Class: See Line 11 of cover sheets. The percentages set forth on the cover sheet for each Reporting Person are calculated based on 31,934,557 shares of Common Stock reported by the Issuer to be outstanding as of April 15, 2014 on Form S-4 as filed with the Securities and Exchange Commission on April 9, 2014.
|
CUSIP No. 379606106
|
Schedule 13G
|
Page 8 of 11 Pages
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote: See Line 5 of cover sheets.
|
|
(ii)
|
shared power to vote or to direct the vote: See Line 6 of cover sheets.
|
|
(iii)
|
sole power to dispose or to direct the disposition of: See Line 7 of cover sheets.
|
|
(iv)
|
shared power to dispose or to direct the disposition of: See Line 8 of cover sheets.
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
|
By signing below I certify that to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
CUSIP No. 379606106
|
Schedule 13G
|
Page 9 of 11 Pages
|
By:
|
OBP Management V L.P.
|
|
General Partner
|
By:
|
*
|
By:
|
OBP Management V L.P.
|
|
General Partner
|
By:
|
*
|
By:
|
*
|
*
|
*
|
*By:
|
/s/ Andrea Costantino | ||
Andrea Costantino | |||
As attorney-in-fact |
CUSIP No. 379606106
|
Schedule 13G
|
Page 10 of 11 Pages
|
By:
|
OBP Management V L.P.
|
|
General Partner
|
By:
|
*
|
By:
|
OBP Management V L.P.
|
|
General Partner
|
By:
|
*
|
By:
|
*
|
*
|
*
|
*By:
|
/s/ Andrea Costantino | ||
Andrea Costantino | |||
As attorney-in-fact |
CUSIP No. 379606106
|
Schedule 13G
|
Page 11 of 11 Pages
|